comprehensive review on phytochemicals for fatty liver: are they potential adjuvants

Full text
Author(s):	do Moinho, Tais Menezes ^[1] ; Matos, Sandro Leao ^[1] ; Carvalho, Carla R. O. ^[1] Total Authors: 3
Affiliation:	^[1] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, BR-05508000 Sao Paulo - Brazil Total Affiliations: 1
Document type:	Review article
Source:	JOURNAL OF MOLECULAR MEDICINE-JMM; v. 100, n. 3 JAN 2022.
Web of Science Citations:	0
Abstract
Non-alcoholic fatty liver disease (NAFLD) is considered the hepatic manifestation of metabolic syndrome and, as such, is associated with obesity. With the current and growing epidemic of obesity, NAFLD is already considered the most common liver disease in the world. Currently, there is no official treatment for the disease besides weight loss. Although there are a few synthetic drugs currently being studied, there is also an abundance of herbal products that could also be used for treatment. With the World Health Organization (WHO) traditional medicine strategy (2014-2023) in mind, this review aims to analyze the mechanisms of action of some of these herbal products, as well as evaluate toxicity and herb-drug interactions available in literature. (AU)

FAPESP's process:	19/20464-8 - Kombucha and its interaction between bile acids, gut microbiota composition and intestinal inflammatory state
Grantee:	Carla Roberta de Oliveira Carvalho
Support Opportunities:	Regular Research Grants